| Title | Author(s) | Year | View Count |
 | Expression of c-myc, c-fos, and c-jun in hepatocellular carcinoma | Yuen, MF; Wu, PC; Lai, VCH; Lau, JYN; Lai, CL | 2001 | 107 |
 | Extended lamivudine treatment in patients with chronic hepatitis B enhances hepatiits B e antigen seroconversion rate: results after 3 years of therapy | Leung, NW; Lai, CL; Chang, TT; Guan, R; Lee, CM; Ng, KY; Lim, SG; Wu, PC; Dent, JC; Edmundson, S; Condreay, LD; Chien, RN | 2001 | 115 |
| Extended lamivudine treatment in patients with chronic hepatitis B enhances hepatitis B e antigen seroconversion rates: Results after 3 years of therapy | Leung, NWY; Lai, CL; Chang, TT; Guan, R; Lee, CM; Ng, KY; Lim, SG; Wu, PC; Dent, JC; Edmundson, S; Condreay, LD; Chien, RN | 2001 | 62 |
| Antituberculosis drug-related liver dysfunction in chronic hepatitis B infection | Wong, WM; Wu, PC; Yuen, MF; Cheng, CC; Yew, WW; Wong, PC; Tam, CM; Leung, CC; Lai, CL | 2000 | 106 |
| Imbalance between cell proliferation and cellular DNA fragmentation in hepatocellular carcinoma | Wu, PC; Lau, VKT; Fang, JWS; Lai, VCH; Lai, CL; Lau, JYN | 1999 | 94 |
| Treatment of hepatitis B exacerbation with lamivudine after renal transplantation | Chan, DTM; Li, FK; Fang, GX; Wu, PC; Lo, CY; Cheng, IKP; Lai, CL; Lai, KN | 1999 | 77 |
| Case report: Histological changes during clearance of chronic hepatitis B virus infection by adoptive immunity transfer | Lau, GKK; Yuen, ST; Au, WY; Wu, PC; Liang, R | 1999 | 69 |
| Hepatocellular carcinoma expressing both hepatocellular and biliary markers also expresses cytokeratin 14, a marker of bipotential progenitor cells [3] | Wu, PC; Lai, VCH; Fang, JWS; Gerber, MA; Lai, CL; Lau, JYN | 1999 | 36 |
 | Hepatitis C virus genotypes in patients on renal replacement therapy | Chan, TM; Lau, JYN; Wu, PC; Lai, CL; Lok, ASF; Cheng, IKP | 1998 | 234 |
| Treatment of fibrosing cholestatic hepatitis with lamivudine | Chan, TM; Wu, PC; Li, FK; Lai, CL; Cheng, IKP; Lai, KN | 1998 | 79 |
| Use of famciclovir to prevent HBV reactivation in HBsAg-positive recipients after allogeneic bone marrow transplantation | Lau, G; Liang, RHS; Wu, PC; Lee, CK; Lim, WWL; Au, WY | 1998 | 89 |
| Raised serum hCG in a male patient caused by primary jejunal choriocarcinoma | Chan, GSW; Ng, WK; Chua, DTT; Wu, PC | 1998 | 312 |
| A one-year trial of lamivudine for chronic hepatitis B | Lai, CL; Chien, RN; Leung, NWY; Chang, TT; Guan, R; Tai, DI; Ng, KY; Wu, PC; Dent, JC; Barber, J; Stephenson, SL; Gray, DF | 1998 | 322 |
| Desmoplastic variant of ameloblastoma in Chinese patients | Lam, KY; Chan, ACL; Wu, PC; Chau, KY; Tideman, H; Wei, W | 1998 | 110 |
| Use of famciclovir to prevent HPV reactivation in HBsAg-positive recipients after allogeneic bone marrow transplantation | Lau, GKK; Liang, R; Wu, PC; Lee, CK; Lim, WL; Au, WY | 1998 | 74 |
| Use of famciclovir to prevent HBV reactivation in HBsAg-positive recipients after allogeneic bone marrow transplantation | Lau, G; Liang, RHS; Wu, PC; Lee, CK; Lim, WL; Au, WY | 1998 | 64 |
| The clinical and histological features of serum hepatitis B antigen clearance after allogeneic bone marrow transplantation | Liang, RHS; Lau, G; Au, WY; Lee, CK; Chim, JCS; Lie, AKW; Chen, FE; Kwong, YL; Yuen, ST; Wu, PC | 1998 | 77 |
| Treatment of hepatitis B exacerbation with lamivudine after renal transplantation (RT) | Chan, DTM; Li, FK; Fang, GX; Lui, SL; Wu, PC; Lo, CY; Cheng, IKP; Lai, CL; Lai, KN | 1998 | 73 |
| The relative pathogenicity of Candida krusei and C. albicans in the rat oral mucosa | Samaranayake, YH; Wu, PC; Samaranayake, LP; Ho, PL | 1998 | 75 |
| Lamivudine is effective in suppressing hepatitis B virus DNA in Chinese hepatitis B surface antigen carriers: A placebo-controlled trial | Lai, CL; Ching, CK; Tung, AKM; Li, E; Young, J; Hill, A; Wong, BCY; Dent, J; Wu, PC | 1997 | 119 |
|
